CN109316557A - Compound traditional Chinese medicine composite of the anti-hypertension Renal Injury with carotid atherosclerosis - Google Patents
Compound traditional Chinese medicine composite of the anti-hypertension Renal Injury with carotid atherosclerosis Download PDFInfo
- Publication number
- CN109316557A CN109316557A CN201811516956.1A CN201811516956A CN109316557A CN 109316557 A CN109316557 A CN 109316557A CN 201811516956 A CN201811516956 A CN 201811516956A CN 109316557 A CN109316557 A CN 109316557A
- Authority
- CN
- China
- Prior art keywords
- weight fraction
- tuber
- atractylodis macrocephalae
- gorgon fruit
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000006378 damage Effects 0.000 title claims abstract description 37
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 208000027418 Wounds and injury Diseases 0.000 title claims abstract description 30
- 150000001875 compounds Chemical class 0.000 title claims abstract description 30
- 208000014674 injury Diseases 0.000 title claims abstract description 30
- 206010038464 renal hypertension Diseases 0.000 title claims abstract description 30
- 239000002131 composite material Substances 0.000 title claims abstract description 29
- 208000014882 Carotid artery disease Diseases 0.000 title claims abstract description 26
- 208000037876 carotid Atherosclerosis Diseases 0.000 title claims abstract description 26
- 239000000843 powder Substances 0.000 claims abstract description 59
- 244000268590 Euryale ferox Species 0.000 claims abstract description 44
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 44
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 44
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 44
- 241001522129 Pinellia Species 0.000 claims abstract description 44
- 241000205407 Polygonum Species 0.000 claims abstract description 44
- 241000405911 Rehmannia glutinosa Species 0.000 claims abstract description 44
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 39
- 239000000463 material Substances 0.000 claims abstract description 23
- 210000003734 kidney Anatomy 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 206010020772 Hypertension Diseases 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 201000001320 Atherosclerosis Diseases 0.000 claims abstract description 5
- 238000005303 weighing Methods 0.000 claims abstract 3
- 239000007788 liquid Substances 0.000 claims description 24
- 238000001914 filtration Methods 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 7
- 230000003068 static effect Effects 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 210000003127 knee Anatomy 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 230000036772 blood pressure Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 150000002632 lipids Chemical class 0.000 abstract description 3
- 206010016654 Fibrosis Diseases 0.000 abstract description 2
- 230000004761 fibrosis Effects 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 239000004072 C09CA03 - Valsartan Substances 0.000 description 1
- 206010061481 Renal injury Diseases 0.000 description 1
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
- HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 description 1
- 229960000528 amlodipine Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 229960002855 simvastatin Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 description 1
- 229960004699 valsartan Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of anti-hypertension Renal Injuries with the compound traditional Chinese medicine composite of carotid atherosclerosis, raw material including following parts by weight: Rehmannia glutinosa 10-90g, Gorgon fruit 8-60g, Rhizoma Gastrodiae 2-30g, Radix Notoginseng powder 1-20g, radix cyathulae 3-30g, polygonum cuspidate 2-20g, Rhizoma Atractylodis Macrocephalae 5-30g and tuber of pinellia 2-26g processed, preparation method includes the following steps: weighing Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, radix cyathulae, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed in proportion, first Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed mix and add water submerged.Present invention preparation is simple, pass through the compound traditional Chinese medicine composite of decoction and the available anti-hypertension Renal Injury companion carotid atherosclerosis of concentration to medicinal material, hypertension early-stage kidney damage kidneys of patients progression of fibrosis can be effectively relieved, mitigate kidneys of patients burden, and effective alleviation atherosclerosis crowd symptom, effective blood pressure lowering and reducing blood lipid, Small side effects are not likely to produce tolerance.
Description
Technical field
The answering with carotid atherosclerosis the present invention relates to field of medicaments more particularly to a kind of anti-hypertension Renal Injury
Square Chinese medicine composition.
Background technique
China's adult hypertension illness rate is 18.8%, there is hypertensive patient about 1.6 hundred million at present.Since kidney is hypertension
One of first target organs of damage, data show that as caused by hypertension kidney damage and enter chronic renal insufficiency
Patient numbers are in increase year by year, therefore how to prevent and treat Kidney Damage by Hypertensive Disease, especially Renal Injury, and the development of the state of an illness is delayed to have
There is highly important clinical meaning, atherosclerosis is one of the common disease for seriously endangering human health, frequently-occurring disease.In west
National atherosclerotic cardiovascular disease is referred to as " number one killer ", practises as our people's living standard is improved with diet
Used change, the disease also become the major causes of death in China.
Clinic mainly based on the western medicine of reducing blood lipid and blood pressure lowering, needs Long-term taking medicine, and side effect is more, easily produces
Raw tolerance, so we provide anti-hypertension Renal Injuries with the compound traditional Chinese medicine composite of carotid atherosclerosis, use
It is set forth above in solving the problems, such as.
Summary of the invention
Technical problems based on background technology, the invention proposes a kind of anti-hypertension Renal Injuries with arteria carotis
The compound traditional Chinese medicine composite of atherosis.
The compound traditional Chinese medicine composite of anti-hypertension Renal Injury companion carotid atherosclerosis proposed by the present invention, including with
The raw material of lower parts by weight: Rehmannia glutinosa 10-90g, Gorgon fruit 8-60g, Rhizoma Gastrodiae 2-30g, Radix Notoginseng powder 1-20g, radix cyathulae 3-30g, polygonum cuspidate
2-20g, Rhizoma Atractylodis Macrocephalae 5-30g and tuber of pinellia 2-26g processed.
Preparation method includes the following steps: weigh in proportion Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, radix cyathulae, polygonum cuspidate,
Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed are first mixed and add water submerged by Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed,
Again by radix cyathulae and plus water submerged, static 5-15min pours out water after stirring, the cleaning to medicinal material is completed, by radix cyathulae
Powder is dried and be ground into, medicinal material total weight 9- is added to Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed
16 times of warm water impregnates 10-15min, then decocts 1.5-3.5 hours, and decocting liquid is obtained by filtration, adds medicinal material total weight 6-10
Warm water again decocts 1-2 hours, decocting liquid is obtained by filtration, two decocting liquids are merged and filtered, filtrate are obtained, by radix cyathulae
Powder be added in filtrate, be sufficiently stirred, mixed liquor be concentrated into medicinal extract, it is dry and crush anti-hypertension morning can be obtained
Compound traditional Chinese medicine composite of the phase renal damage with carotid atherosclerosis.
Preferably, the weight fraction of the Rehmannia glutinosa is 20-80g, the weight fraction of Gorgon fruit is 20-50g, the weight of Rhizoma Gastrodiae
Score is 10-20g, the weight fraction of Radix Notoginseng powder is 5-20g, the weight fraction of radix cyathulae is 3-12g, the weight fraction of polygonum cuspidate is
2-15g, Rhizoma Atractylodis Macrocephalae weight fraction be 5-30g and the weight fraction of the tuber of pinellia processed is 2-26g.
Preferably, the temperature of the warm water is 40-50 DEG C.
Preferably, the weight fraction of the Rehmannia glutinosa is 10-90g, the weight fraction of Gorgon fruit is 8-60g, the weight of Rhizoma Gastrodiae
Score is 2-30g, the weight fraction of Radix Notoginseng powder is 10-15g, the weight fraction of radix cyathulae is 5-8g, the weight fraction of polygonum cuspidate is
6-12g, Rhizoma Atractylodis Macrocephalae weight fraction be 5-30g and the weight fraction of the tuber of pinellia processed is 2-26g.
Preferably, the weight fraction of the Rehmannia glutinosa is 10-90g, the weight fraction of Gorgon fruit is 8-60g, the weight of Rhizoma Gastrodiae
Score is 2-30g, the weight fraction of Radix Notoginseng powder is 5-20g, the weight fraction of radix cyathulae is 3-12g, the weight fraction of polygonum cuspidate is
2-15g, Rhizoma Atractylodis Macrocephalae weight fraction be 8-20g and the weight fraction of the tuber of pinellia processed is 8-19g.
Preferably, the weight fraction of the Rehmannia glutinosa is 30-60g, the weight fraction of Gorgon fruit is 8-60g, the weight of Rhizoma Gastrodiae
Score is 2-30g, the weight fraction of Radix Notoginseng powder is 10-15g, the weight fraction of radix cyathulae is 3-12g, the weight fraction of polygonum cuspidate is
2-15g, Rhizoma Atractylodis Macrocephalae weight fraction be 8-20g and the weight fraction of the tuber of pinellia processed is 2-26g.
Preferably, the weight fraction of the Rehmannia glutinosa is 10-90g, the weight fraction of Gorgon fruit is 30-50g, the weight of Rhizoma Gastrodiae
Score is 2-30g, the weight fraction of Radix Notoginseng powder is 5-20g, the weight fraction of radix cyathulae is 3-12g, the weight fraction of polygonum cuspidate is
5-10g, Rhizoma Atractylodis Macrocephalae weight fraction be 12-22g and the weight fraction of the tuber of pinellia processed is 9-18g.
Preferably, the weight fraction of the Rehmannia glutinosa is 10-90g, the weight fraction of Gorgon fruit is 30-45g, the weight of Rhizoma Gastrodiae
Score is 2-30g, the weight fraction of Radix Notoginseng powder is 5-20g, the weight fraction of radix cyathulae is 3-12g, the weight fraction of polygonum cuspidate is
6-9g, Rhizoma Atractylodis Macrocephalae weight fraction be 12-22g and the weight fraction of the tuber of pinellia processed is 9-18g.
Preferably, the weight fraction of the Rehmannia glutinosa is 25-80g, the weight fraction of Gorgon fruit is 25-45g, the weight of Rhizoma Gastrodiae
Score is 2-30g, the weight fraction of Radix Notoginseng powder is 5-20g, the weight fraction of radix cyathulae is 3-8g, the weight fraction of polygonum cuspidate is 5-
10g, Rhizoma Atractylodis Macrocephalae weight fraction be 12-19g and the weight fraction of the tuber of pinellia processed is 9-18g.
Preferably, in preparation process, Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, radix cyathulae, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae are weighed in proportion
With the tuber of pinellia processed, first Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed are mixed and add water submerged, then will
Radix cyathulae adds water submerged, and static 9-12min pours out water after stirring, completes the cleaning to medicinal material, simultaneously by radix cyathulae drying
It is ground into powder, 10-14 times of medicinal material total weight is added to Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed
Warm water impregnates 12-14min, then decocts 2-3 hours, and decocting liquid is obtained by filtration, adds the warm water of 7-9 times of medicinal material total weight, decocts
It boils 1.5-2 hours, decocting liquid is obtained by filtration, two decocting liquids are merged and filtered, filtrate is obtained, the powder of radix cyathulae is added
It in filtrate, is sufficiently stirred, mixed liquor is concentrated into medicinal extract, drying and crushing can be obtained anti-hypertension Renal Injury companion
The compound traditional Chinese medicine composite of carotid atherosclerosis.
The beneficial effects of the present invention are: by adding to Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed
Water decocts available decocting liquid, and the powder by the way that radix cyathulae is added into decocting liquid is sufficiently stirred and mixed liquor is concentrated
To medicinal extract, compound traditional Chinese medicine composite that is dry and crushing available anti-hypertension Renal Injury companion carotid atherosclerosis,
Present invention preparation is simple, athero- hard with arteria carotis by decoction to medicinal material and the available anti-hypertension Renal Injury of concentration
Hypertension early-stage kidney damage kidneys of patients progression of fibrosis can be effectively relieved in the compound traditional Chinese medicine composite of change, mitigate patient's kidney
Dirty burden, and effective alleviation atherosclerosis crowd symptom, effective blood pressure lowering and reducing blood lipid, Small side effects, are not easy to produce
Raw tolerance.
Specific embodiment
Combined with specific embodiments below the present invention is made further to explain.
Embodiment one
The invention proposes anti-hypertension Renal Injuries with the compound traditional Chinese medicine composite of carotid atherosclerosis, including with
The raw material of lower parts by weight: Rehmannia glutinosa 20g, Gorgon fruit 30g, Rhizoma Gastrodiae 10g, Radix Notoginseng powder 15g, radix cyathulae 5g, polygonum cuspidate 4g, Rhizoma Atractylodis Macrocephalae 8g and system
Tuber of pinellia 8g.
Preparation method includes the following steps: weigh in proportion Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, radix cyathulae, polygonum cuspidate,
Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed are first mixed and add water submerged by Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed,
Radix cyathulae is added into water submerged again, static 8min pours out water after stirring, completes the cleaning to medicinal material, radix cyathulae is dried
And it is ground into powder, 10 times of medicinal material total weight are added to Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed
Warm water impregnates 12min, then decocts 1.5 hours, and decocting liquid is obtained by filtration, and adds 7 times of medicinal material total weight of warm water, and it is small to decoct 1
When, decocting liquid is obtained by filtration, two decocting liquids are merged and filtered, filtrate is obtained, the powder of radix cyathulae is added in filtrate, into
It goes and is sufficiently stirred, mixed liquor is concentrated into medicinal extract, drying and crushing can be obtained anti-hypertension Renal Injury with arteria carotis congee
The compound traditional Chinese medicine composite of sample hardening.
Embodiment two
The invention proposes anti-hypertension Renal Injuries with the compound traditional Chinese medicine composite of carotid atherosclerosis, including with
The raw material of lower parts by weight: Rehmannia glutinosa 60g, Gorgon fruit 50g, Rhizoma Gastrodiae 20g, Radix Notoginseng powder 15g, radix cyathulae 8g, polygonum cuspidate 6g, Rhizoma Atractylodis Macrocephalae 15g and
Tuber of pinellia 12g processed.
Preparation method includes the following steps: weigh in proportion Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, radix cyathulae, polygonum cuspidate,
Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed are first mixed and add water submerged by Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed,
Radix cyathulae is added into water submerged again, static 10min pours out water after stirring, completes the cleaning to medicinal material, radix cyathulae is dried
And it is ground into powder, 12 times of medicinal material total weight are added to Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed
Warm water impregnates 12min, then decocts 2 hours, and decocting liquid is obtained by filtration, and adds 8 times of medicinal material total weight of warm water, and it is small to decoct 1.5
When, decocting liquid is obtained by filtration, two decocting liquids are merged and filtered, filtrate is obtained, the powder of radix cyathulae is added in filtrate, into
It goes and is sufficiently stirred, mixed liquor is concentrated into medicinal extract, drying and crushing can be obtained anti-hypertension Renal Injury with arteria carotis congee
The compound traditional Chinese medicine composite of sample hardening.
Embodiment three
The invention proposes anti-hypertension Renal Injuries with the compound traditional Chinese medicine composite of carotid atherosclerosis, including with
The raw material of lower parts by weight: Rehmannia glutinosa 15g, Gorgon fruit 30g, Rhizoma Gastrodiae 10g, Radix Notoginseng powder 3g, radix cyathulae 15g, polygonum cuspidate 15g, Rhizoma Atractylodis Macrocephalae 10g and
Tuber of pinellia 10g processed.
Preparation method includes the following steps: weigh in proportion Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, radix cyathulae, polygonum cuspidate,
Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed are first mixed and add water submerged by Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed,
Radix cyathulae is added into water submerged again, static 12min pours out water after stirring, completes the cleaning to medicinal material, radix cyathulae is dried
And it is ground into powder, 15 times of medicinal material total weight are added to Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed
Warm water impregnates 13min, then decocts 3 hours, and decocting liquid is obtained by filtration, and adds 9 times of medicinal material total weight of warm water, and it is small to decoct 1.8
When, decocting liquid is obtained by filtration, two decocting liquids are merged and filtered, filtrate is obtained, the powder of radix cyathulae is added in filtrate, into
It goes and is sufficiently stirred, mixed liquor is concentrated into medicinal extract, drying and crushing can be obtained anti-hypertension Renal Injury with arteria carotis congee
The compound traditional Chinese medicine composite of sample hardening.
Herbal mixture to anti-hypertension Renal Injury made from embodiment one to three with carotid atherosclerosis combines
Object, comparison valsartan amlodipine piece (Novartis Pharma Schweiz AG, authentication code: traditional Chinese medicines H20090840, specification: 80 millis
Gram: 5 milligrams /) and Simvastatin, it is shown that the experimental data are shown in the following table:
By above table it is found that anti-hypertension Renal Injury proposed by the present invention is in the compound of carotid atherosclerosis
Drug composition, which has, to be significantly improved, and embodiment three is most preferred embodiment.
The foregoing is only a preferred embodiment of the present invention, but scope of protection of the present invention is not limited thereto,
Anyone skilled in the art in the technical scope disclosed by the present invention, according to the technique and scheme of the present invention and its
Inventive concept is subject to equivalent substitution or change, should be covered by the protection scope of the present invention.
Claims (10)
1. anti-hypertension Renal Injury is with the compound traditional Chinese medicine composite of carotid atherosclerosis, which is characterized in that including following
The raw material of parts by weight: Rehmannia glutinosa 10-90g, Gorgon fruit 8-60g, Rhizoma Gastrodiae 2-30g, Radix Notoginseng powder 1-20g, radix cyathulae 3-30g, polygonum cuspidate 2-
20g, Rhizoma Atractylodis Macrocephalae 5-30g and tuber of pinellia 2-26g processed.
Preparation method includes the following steps: weighing Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, radix cyathulae, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae in proportion
With the tuber of pinellia processed, first Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed are mixed and add water submerged, then will
Radix cyathulae adds water submerged, and static 5-15min pours out water after stirring, completes the cleaning to medicinal material, simultaneously by radix cyathulae drying
It is ground into powder, 9-16 times of medicinal material total weight is added to Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed
Warm water impregnates 10-15min, then decocts 1.5-3.5 hours, and decocting liquid is obtained by filtration, adds the temperature of 6-10 times of medicinal material total weight
Water decocts 1-2 hours, decocting liquid is obtained by filtration, two decocting liquids are merged and filtered, obtain filtrate, by the powder of radix cyathulae
It is added in filtrate, is sufficiently stirred, mixed liquor is concentrated into medicinal extract, drying and crushing can be obtained anti-hypertension early stage kidney damage
Compound traditional Chinese medicine composite of the evil with carotid atherosclerosis.
2. the compound traditional Chinese medicine composite of anti-hypertension Renal Injury companion carotid atherosclerosis according to claim 1,
It is characterized in that, the weight fraction of the Rehmannia glutinosa is 20-80g, the weight fraction of Gorgon fruit is 20-50g, the weight fraction of Rhizoma Gastrodiae
Weight fraction for 10-20g, Radix Notoginseng powder is 5-20g, the weight fraction of radix cyathulae is 3-12g, the weight fraction of polygonum cuspidate is 2-
15g, Rhizoma Atractylodis Macrocephalae weight fraction be 5-30g and the weight fraction of the tuber of pinellia processed is 2-26g.
3. the compound traditional Chinese medicine composite of anti-hypertension Renal Injury companion carotid atherosclerosis according to claim 1,
It is characterized in that, the temperature of the warm water is 40-50 DEG C.
4. the compound traditional Chinese medicine composite of anti-hypertension Renal Injury companion carotid atherosclerosis according to claim 1,
It is characterized in that, the weight fraction of the Rehmannia glutinosa is 10-90g, the weight fraction of Gorgon fruit is 8-60g, the weight fraction of Rhizoma Gastrodiae
Weight fraction for 2-30g, Radix Notoginseng powder is 10-15g, the weight fraction of radix cyathulae is 5-8g, the weight fraction of polygonum cuspidate is 6-
12g, Rhizoma Atractylodis Macrocephalae weight fraction be 5-30g and the weight fraction of the tuber of pinellia processed is 2-26g.
5. the compound traditional Chinese medicine composite of anti-hypertension Renal Injury companion carotid atherosclerosis according to claim 1,
It is characterized in that, the weight fraction of the Rehmannia glutinosa is 10-90g, the weight fraction of Gorgon fruit is 8-60g, the weight fraction of Rhizoma Gastrodiae
Weight fraction for 2-30g, Radix Notoginseng powder is 5-20g, the weight fraction of radix cyathulae is 3-12g, the weight fraction of polygonum cuspidate is 2-
15g, Rhizoma Atractylodis Macrocephalae weight fraction be 8-20g and the weight fraction of the tuber of pinellia processed is 8-19g.
6. the compound traditional Chinese medicine composite of anti-hypertension Renal Injury companion carotid atherosclerosis according to claim 1,
It is characterized in that, the weight fraction of the Rehmannia glutinosa is 30-60g, the weight fraction of Gorgon fruit is 8-60g, the weight fraction of Rhizoma Gastrodiae
Weight fraction for 2-30g, Radix Notoginseng powder is 10-15g, the weight fraction of radix cyathulae is 3-12g, the weight fraction of polygonum cuspidate is 2-
15g, Rhizoma Atractylodis Macrocephalae weight fraction be 8-20g and the weight fraction of the tuber of pinellia processed is 2-26g.
7. the compound traditional Chinese medicine composite of anti-hypertension Renal Injury companion carotid atherosclerosis according to claim 1,
It is characterized in that, the weight fraction of the Rehmannia glutinosa is 10-90g, the weight fraction of Gorgon fruit is 30-50g, the weight fraction of Rhizoma Gastrodiae
Weight fraction for 2-30g, Radix Notoginseng powder is 5-20g, the weight fraction of radix cyathulae is 3-12g, the weight fraction of polygonum cuspidate is 5-
10g, Rhizoma Atractylodis Macrocephalae weight fraction be 12-22g and the weight fraction of the tuber of pinellia processed is 9-18g.
8. the compound traditional Chinese medicine composite of anti-hypertension Renal Injury companion carotid atherosclerosis according to claim 1,
It is characterized in that, the weight fraction of the Rehmannia glutinosa is 10-90g, the weight fraction of Gorgon fruit is 30-45g, the weight fraction of Rhizoma Gastrodiae
Weight fraction for 2-30g, Radix Notoginseng powder is 5-20g, the weight fraction of radix cyathulae is 3-12g, the weight fraction of polygonum cuspidate be 6-9g,
The weight fraction of Rhizoma Atractylodis Macrocephalae is 12-22g and the weight fraction of the tuber of pinellia processed is 9-18g.
9. the compound traditional Chinese medicine composite of anti-hypertension Renal Injury companion carotid atherosclerosis according to claim 1,
It is characterized in that, the weight fraction of the Rehmannia glutinosa is 25-80g, the weight fraction of Gorgon fruit is 25-45g, the weight fraction of Rhizoma Gastrodiae
Weight fraction for 2-30g, Radix Notoginseng powder is 5-20g, the weight fraction of radix cyathulae is 3-8g, the weight fraction of polygonum cuspidate be 5-10g,
The weight fraction of Rhizoma Atractylodis Macrocephalae is 12-19g and the weight fraction of the tuber of pinellia processed is 9-18g.
10. the compound traditional Chinese medicine composite of anti-hypertension Renal Injury companion carotid atherosclerosis according to claim 1,
It is characterized in that, weighing Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, radix cyathulae, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and system in proportion in preparation process
Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed are first mixed and add water submerged by the tuber of pinellia, then by river ox
Knee adds water submerged, and static 9-12min pours out water after stirring, completes the cleaning to medicinal material, radix cyathulae is dried and crushed
At powder, the temperature of 10-14 times of medicinal material total weight is added to Rehmannia glutinosa, Gorgon fruit, Rhizoma Gastrodiae, Radix Notoginseng powder, polygonum cuspidate, Rhizoma Atractylodis Macrocephalae and the tuber of pinellia processed
Water impregnates 12-14min, then decocts 2-3 hours, and decocting liquid is obtained by filtration, adds the warm water of 7-9 times of medicinal material total weight, decocts
1.5-2 hours, decocting liquid is obtained by filtration, two decocting liquids are merged and filtered, filtrate is obtained, filter is added in the powder of radix cyathulae
It in liquid, is sufficiently stirred, mixed liquor is concentrated into medicinal extract, drying and crushing can be obtained anti-hypertension Renal Injury with neck
The compound traditional Chinese medicine composite of atherosclerosis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811516956.1A CN109316557A (en) | 2018-12-12 | 2018-12-12 | Compound traditional Chinese medicine composite of the anti-hypertension Renal Injury with carotid atherosclerosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811516956.1A CN109316557A (en) | 2018-12-12 | 2018-12-12 | Compound traditional Chinese medicine composite of the anti-hypertension Renal Injury with carotid atherosclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109316557A true CN109316557A (en) | 2019-02-12 |
Family
ID=65256286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811516956.1A Pending CN109316557A (en) | 2018-12-12 | 2018-12-12 | Compound traditional Chinese medicine composite of the anti-hypertension Renal Injury with carotid atherosclerosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109316557A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843803A (en) * | 2009-10-28 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating diabetic nephropathy |
| CN101843696A (en) * | 2009-10-16 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating diabetic nephropathy |
| CN102793826A (en) * | 2012-09-04 | 2012-11-28 | 柳州市中医院 | Traditional Chinese medicine for treating hypertension early-stage kidney damage and preparation method thereof |
| CN104887766A (en) * | 2015-05-27 | 2015-09-09 | 胡怀强 | Traditional Chinese medicine compound capsules for treating atherosclerosis and preparation method thereof |
-
2018
- 2018-12-12 CN CN201811516956.1A patent/CN109316557A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843696A (en) * | 2009-10-16 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating diabetic nephropathy |
| CN101843803A (en) * | 2009-10-28 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating diabetic nephropathy |
| CN102793826A (en) * | 2012-09-04 | 2012-11-28 | 柳州市中医院 | Traditional Chinese medicine for treating hypertension early-stage kidney damage and preparation method thereof |
| CN104887766A (en) * | 2015-05-27 | 2015-09-09 | 胡怀强 | Traditional Chinese medicine compound capsules for treating atherosclerosis and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 张金玺: "补肾祛痰熄风汤联合西药治疗椎/基底动脉供血不足性眩晕64例", 《新中医》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102512621B (en) | Preparation method of Yunkang capsule | |
| CN103990081A (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for treating infant jaundice | |
| CN102343023A (en) | Medicinal composition and preparation method and application thereof | |
| CN102973719A (en) | Traditional Chinese medicine health-care food with bowel relaxing function and preparation method thereof | |
| CN103191298A (en) | Traditional Chinese medicinal composition for treating blood group incompatibility haemolytic disease and preparation method thereof | |
| CN103285319B (en) | Chinese medicine composition for Polycystic Ovary Syndrome in Adolescence | |
| CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN104001096A (en) | Medicine for treating acute gastroenteritis | |
| CN109316557A (en) | Compound traditional Chinese medicine composite of the anti-hypertension Renal Injury with carotid atherosclerosis | |
| CN103705860B (en) | A kind of Chinese medicine composition for the treatment of infant jaundice and preparation method thereof | |
| CN105560475A (en) | Traditional Chinese medicine composition for preventing chemical liver injury and preparation method thereof | |
| CN105362776A (en) | Traditional Chinese medicinal composition for treating hyperthyroidism as well as preparation method and application of traditional Chinese medicinal composition | |
| CN100356963C (en) | Anti-thrombosis blood fat-reducing blood pressure-decreasing oral liquid | |
| CN105456754A (en) | Traditional Chinese medicine for treating insomnia and preparation method thereof | |
| CN103721187A (en) | Blood-circulation-promoting and blood-fat-reducing pill for treating hyperlipemia and preparation method of pill | |
| CN106362067A (en) | Roxburg rose fruit appetite improving and digestion promoting drug composition and preparation method thereof | |
| CN1115159C (en) | Red sage containing medicine composition and its preparation and use | |
| CN102552828B (en) | Liver protecting medicine and preparation method thereof | |
| CN106974981A (en) | A kind of external used medicine of analgesic | |
| CN101380365A (en) | Baicao Shenqing traditional Chinese medicine composition and preparation method thereof | |
| CN104225008B (en) | A kind of Chinese medicine composition treating metabolism syndrome and preparation method thereof and Chinese medicine preparation | |
| CN105641621B (en) | Phlegm and blood stasis treating granule and taking method thereof | |
| CN103070337A (en) | Defaecation-promoting health-care food and preparation method thereof | |
| CN103285110B (en) | Traditional Chinese medicine for treating hyperlipidemia and preparation method thereof | |
| CN102406910A (en) | Composition for increasing immunity and preventing and treating rheumatism, rheumatoid diseases and herniated disk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190212 |